share_log

海吉亞醫療:翌日披露報表

HYGEIA HEALTH: Next Day Disclosure Return

HKEX ·  Sep 4 18:08

Summary by Futu AI

海吉亞醫療控股有限公司(海吉亞醫療)於2024年9月4日提交了翌日披露報表,披露公司股份變動情況。報告顯示,海吉亞醫療於2024年9月2日至4日進行了股份購回,總計購回股份數目為2,912,200股,佔已發行股份的0.4611%。購回的股份計劃將註銷。購回價格範圍為每股HKD 15.82至HKD 18.2396,總支付價格為HKD 13,299,984。公司確認,所有購回活動均按照香港聯合交易所有限公司主板及GEM上市規則進行,並已獲得董事會批准。此外,公司於2024年6月28日獲得購回授權,並在購回後的30天內,即截至2024年10月4日,將不會進行任何新股發行或庫存股份再出售或轉讓。
海吉亞醫療控股有限公司(海吉亞醫療)於2024年9月4日提交了翌日披露報表,披露公司股份變動情況。報告顯示,海吉亞醫療於2024年9月2日至4日進行了股份購回,總計購回股份數目為2,912,200股,佔已發行股份的0.4611%。購回的股份計劃將註銷。購回價格範圍為每股HKD 15.82至HKD 18.2396,總支付價格為HKD 13,299,984。公司確認,所有購回活動均按照香港聯合交易所有限公司主板及GEM上市規則進行,並已獲得董事會批准。此外,公司於2024年6月28日獲得購回授權,並在購回後的30天內,即截至2024年10月4日,將不會進行任何新股發行或庫存股份再出售或轉讓。
Hygeia Health Holdings Limited (Hygeia Health) submitted its next day disclosure form on September 4, 2024, disclosing the changes in the company's shares. The report shows that Hygeia Health conducted share repurchases from September 2 to 4, 2024, with a total of 2,912,200 shares repurchased, accounting for 0.4611% of the issued shares. The repurchased shares will be cancelled. The repurchase price ranged from HKD 15.82 to HKD 18.2396 per share, with a total payment of HKD 13,299,984. The company confirms that all repurchase activities are conducted in accordance with the Main Board and GEM Listing Rules of the Stock Exchange of Hong Kong Limited and have obtained approval from the board of directors. In addition, the company obtained repurchase authorization on June 28, 2024, and within 30 days after the repurchase, i.e., until October 4, 2024, there will be no issuance of new shares or resale or transfer of treasury shares.
Hygeia Health Holdings Limited (Hygeia Health) submitted its next day disclosure form on September 4, 2024, disclosing the changes in the company's shares. The report shows that Hygeia Health conducted share repurchases from September 2 to 4, 2024, with a total of 2,912,200 shares repurchased, accounting for 0.4611% of the issued shares. The repurchased shares will be cancelled. The repurchase price ranged from HKD 15.82 to HKD 18.2396 per share, with a total payment of HKD 13,299,984. The company confirms that all repurchase activities are conducted in accordance with the Main Board and GEM Listing Rules of the Stock Exchange of Hong Kong Limited and have obtained approval from the board of directors. In addition, the company obtained repurchase authorization on June 28, 2024, and within 30 days after the repurchase, i.e., until October 4, 2024, there will be no issuance of new shares or resale or transfer of treasury shares.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.